Skip to content
TrustList
P2P Capital logo
Venture capital firm

P2P Capital

Crypto-focused investment firm holding tokens and backing blockchain and Web3 infrastructure projects

P2P Capital cover

About P2P Capital

P2P Capital is an investment firm that puts its money into crypto assets. It holds coins and tokens directly, joins conventional equity fundraising rounds and takes part in decentralised finance. It says it has backed more than ninety projects that make up its picture of long-term Web3 infrastructure.

What P2P Capital offers

  • Token holdings: direct ownership of coins and tokens.
  • Equity investing: participation in traditional fundraising rounds.
  • DeFi and staking: active involvement in decentralised finance and staking.
  • Portfolio of protocols: a list of blockchain networks and protocols covering smart contracts, governance, oracles, lending and asset management.

Key facts

  • Focus: blockchain and Web3 infrastructure
  • Projects backed: more than 90
  • Regulatory note: the firm states that it has no adviser registration with the US securities regulator, and that its website gives general information only, not advice or an offer of securities

Profile written by TrustList from the business's own published information, Sep 2026.

Ask TrustList to introduce you to P2P Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of P2P Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about P2P Capital.

P2P Capital alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication

Life science investor putting money into young oncology and genetic disease drug developers

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it